Single nucleotide polymorphisms (SNPs) are inherited from parents and they measure heritable events

Journal of Carcinogenesis

Volumn 4, Issue , 2005, Pages

  Hemminki, Kari ^a,b   Försti, Asta ^a,b   Bermejo, Justo Lorenzo ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Genomics; Genotyping; Interactions; Molecular epidemiology; Multiple comparisons

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CHECKPOINT KINASE 2; CYTOCHROME P450 2D6; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA;

BREAST CANCER; CANCER RISK; DATA BASE; ENVIRONMENTAL FACTOR; FAMILIAL CANCER; FAMILY; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HUMAN; INHERITANCE; KIDNEY CANCER; LEUKEMIA; LUNG CANCER; MELANOMA; OVARY CANCER; PROSTATE CANCER; REVIEW; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; SWEDEN;

EID: 13644267286     PISSN: 14773163     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-3163-4-2     Document Type: Review

References (53)

1. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG: Replication validity of genetic association studies. Nat Genet 2001, 29:306-309.
2. Cardon LR, Bell JI: Association study designs for complex diseases. Nature Reviews Genetics 2001, 2:91-99.
3. Hemminki K, Shields PG: Skilled use of DNA polymorphisms as a tool for polygenic cancers. Carcinogenesis 2002, 23: 79-380.
4. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003, 33:177-182.
5. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N: Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004, 96:434-442.
6. Weiss KM, Terwilliger JD: How many diseases does it take to map a gene with SNPs? Nat Genet 2000, 26:151-157.
7. Wang WY, Todd JA: The usefulness of different density SNP maps for disease association studies of common variants. Hum Mol Genet 2003, 12:3145-3149.
8. Carlson CS, Eberle MA, Rieder MJ, Smith JD, Kruglyak L, Nickerson DA: Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans. Nat Genet 2003, 33:518-521.
9. Doll R, Peto R: The causes of cancer. J Natl Cancer Inst 1981, 66:1191-1309.
10. Parkin DM, Khlat M: Studies of cancer in migrants: rationale and methodology. Eur J Cancer 1996, 32A:761-771.
11. Lichtenstein P, Holm N, Verkasalo PK, Illiado A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K: Environmental and heritable factors in the causation of cancer. N Engl J Med 2000, 343:78-85.
12. Peto J: Cancer epidemiology in the last century and the next decade. Nature 2001, 411:390-395.
13. Czene K, Lichtenstein P, Hemminki K: Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 2002, 99:260-266.
14. Hemminki K, Li X, Czene K: Cancer risks in first generation immigrants to Sweden. Int J Cancer 2002, 99: 18-228.
15. Hemminki K, Li X: Cancer risks in second-generation immigrants to Sweden. Int J Cancer 2002, 99:229-237.
16. Hampel H, Sweet K, Westman JA, Offit K, Eng C: Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 2004, 41:81-91.
17. de Jong MM, Nolte IM, te Meerman GJ, van der Graaf WT, Oosterwijk JC, Kleibeuker JH, Schaapveld M, de Vries EG: Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet 2002, 39:225-242.
18. De Jong MM, Nolte IM, Te Meerman GJ, Van Der Graaf WT, De Vries EG, Sijmons RH, Hofstra RM, Kleibeuker JH: Low-penetrance Genes and Their Involvement in Colorectal Cancer Susceptibility. Cancer Epidemiol Biomarkers Prev 2002, 11:1332-1352.
19. Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, Lipscombe JM, Day NE, Easton DF, Ponder BA, Pharoah PD, Dunning A: Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 2002, 11:1399-1407.
20. Haiman CA, Stram DO, Pike MC, Kolonel LN, Burtt NP, Altshuler D, Hirschhorn J, Henderson BE: A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort. Hum Mol Genet 2003, 12:2679-2692.
21. Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD, Easton DF, Day NE, Ponder BA: Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 2004, 96:936-945.
22. Hemminki K, Försti A: Proper controls for SNP studies? Carcinogenesis 2002, 23:1405.
23. Hemminki K, Försti A: Controls need to be selected for the type of SNP study. Carcinogenesis 2002, 23:1405.
24. Houlston RS, Peto J: The future of association studies of common cancers. Hum Genet 2003, 112:434-435.
25. Antoniou AC, Easton DF: Polygenic inheritance of breast cancer: Implications for design of association studies. Genet Epidemiol 2003, 25:190-202.
26. Meijers-Heijboer H, Wijnen J, Vasen H, Wasielewski M, Wagner A, Hollestelle A, Elstrodt F, van den Bos R, de Snoo A, Fat GT, Brekelmans C, Jagmohan S, Franken P, Verkuijlen P, van den Ouweland A, Chapman P, Tops C, Moslein G, Burn J, Lynch H, Klijn J, Fodde R, Schutte M: The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am J Hum Genet 2003, 72:1308-1314.
27. Shields PG, Harris CC: Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 2000, 18:2309-2315.
28. Peltonen L, McKusick VA: Dissecting human diseases in the postgenomic era. Science 2001, 291:1224-1229.
29. Brennan P: Gene-environment interactions and aetiology of cancer: what does it mean and how can we measure it. Carcinogenesis 2002, 23:381-387.
30. dos Santos Silva I: Cancer Epidemiology: Principles and Methods. Lyon, IARC; 1999:442.
31. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M, Hakama M: Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004, 108:104-108.
32. Risch NJ: Searching for genetic determinants in the new millennium. Nature 2000, 405:847-856.
33. Risch N: The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 2001, 10: 33-741.
34. Hemminki K, Li X, Plna K, Granström C, Vaittinen P: The nationwide Swedish Family-Cancer Database: updated structure and familial rates. Acta Oncol 2001, 40:772-777.
35. Hemminki K, Li X, Czene K: Familial risk of cancer: data for clinical counseling and cancer genetics. Int J Cancer 2004, 108:109-114.
36. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR: A census of human cancer genes. Nat Rev Cancer 2004, 4:177-183.
37. Hemminki K, Rawal R, Chen B, Lorenzo Bermejo J: Genetic epidemiology of cancer: from families to heritable genes. Int J Cancer 2004, 111:944-950.
38. Hemminki K, Dong C, Vaittinen P: Cancer risks to spouses and offspring in the Family-Cancer Database. Genet Epidemiol 2001, 20:247-257.
39. Hemminki K, Jiang Y: Cancer risks among long-standing spouses. Br J Cancer 2002, 86:1737-1740.
40. Hemminki K, Li X: Familial risks of cancer as a guide to gene identification and mode of inheritance. Int J Cancer 2004, 110:291-294.
41. Hemminki K, Granström C: Familial breast cancer: scope for more susceptibility genes. Breast Cancer Res Treat 2003, 82:17-22.
42. Hemminki K, Chen B: Familial risk for colorectal cancers are mainly due to heritable causes. Cancer Epidemiol Biomarkers Prev 2004, 13:1253-1256.
43. Hemminki K, Dong C, Vaittinen P: Familial risks in cervix cancer: is there a hereditary component? Int J Cancer 1999, 82:775-781.
44. Li X, Hemminki K: Familial and second lung cancers: a nationwide epidemiologic study from Sweden. Lung Cancer 2003, 39:255-263.
45. Rothman KJ, Greenland S: Modern Epidemiology. 2nd edition. Philadelphia, Lippincott-Raven; 1998.
46. Risch N: Linkage strategies for genetically complex traits. I . Multilocus models. Am J Hum Genet 1990, 46: 22-228.
47. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA: Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002, 31:33-36.
48. IARC: Metabolic polymorphisms and susceptibility to cancer. IARC Sci Publ 1999, 148:1-510.
49. Mace K, Bowman ED, Vautravers P, Shields PG, Harris CC, Pfeifer AM: Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur J Cancer 1998, 34:914-920.
50. Hukkanen J, Pelkonen O, Hakkola J, Raunio H: Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit Rev Toxicol 2002, 32:391-411.
51. Perera FP: Environment and cancer: who are susceptible? Science 1997, 278:1068-1073.
52. Hussain SP, Harris CC: Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens. Mutat Res 2000, 462:311-322.
53. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC: Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 2003, 54: 31-152.